Delivery Order SPE2DB24D9212-SPE2DB24FBUDL

Award Date 8/28/24
Potential Completion Date 9/19/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product Kyleena, a 19.5 mg intrauterine contraceptive system, to the Defense Logistics Agency (DLA). The contract, valued at $9,341.92, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The...
This federal contract award is for the delivery of pharmaceutical products, specifically the Kyleena intrauterine contraceptive system, to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $6,019.30, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has an ultimate completion date of October 9, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $1,209.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the provision of the Kyleena intrauterine contraceptive system. This order was placed against DMS Pharmaceutical Group's indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to...
The federal contract award is for the provision of KYLEENA 19.5 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,757.76, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order contract is a firm fixed-price arrangement, with an ultimate completion date of August 31, 2023. DMS Pharmaceutical Group Inc. holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,009.65 firm fixed-price delivery order is for the supply of the Kyleena 19.5 mg intrauterine system contraceptive device. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program,...
This federal contract award is for the delivery of KYLEENA 19.5 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $2,478.76 and is a firm fixed-price delivery order, with an ultimate completion date of July 17, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery...
This federal contract award is for the delivery of Kyleena 19.5 mg systems to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a total ceiling value of $1,203.86 and is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,098.45, is for the delivery of a single unit of the Kyleena 19.5mg intrauterine system. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The $1,751.58 firm-fixed-price delivery order is for the supply of the pharmaceutical product Kyleena, a 19.5 mg hormonal intrauterine contraceptive system. The contract has no set-aside designation and is part of the larger DLA Single-Award Indefinite Delivery Vehicle (IDV) contract SPE2DB, valued up to $4,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,859.07 contract is for the delivery of the pharmaceutical product Kyleena, a 19.5 mg intrauterine system. The contract has an ultimate completion date of April 7, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
  • SPE2DB24D9212
    Indefinite Delivery Contract
  • SPE2DB24D9212-SPE2DB24FBUDL
    Delivery Order

This federal contract award is for the delivery of the pharmaceutical product Kyleena, a 19.5 mg intrauterine system, to the Defense Logistics Agency (DLA). The contract, valued at $1,805.79, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.

DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 11/27/24, 9:21 AM